PDGFRB and neoplasm: For instance, the fusion of PDGFRβ‐specific affibody ZPDGFRβ with ABD‐TRAIL has been demonstrated to effectively target tumor cells and PDGFRβ‐positive pericytes on tumor microvessels, facilitating the homing of TRAIL to the tumor site [104].